LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$78.19

Market cap

$4.3B

P/E Ratio

39.89

Dividend/share

N/A

EPS

$1.96

Enterprise value

$4.09B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 90

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through ...

Highlights
The net income has soared by 148% YoY and by 144% from the previous quarter
LivaNova's EPS has surged by 148% YoY and by 144% QoQ
LivaNova's quick ratio has decreased by 20% YoY and by 3.8% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com
Peers: OFIX

Key stats

What are the main financial stats of LIVN

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
-0.53%
1 week
-3.11%
1 month
-2.2%
1 year
80.62%
YTD
27.08%
QTD
-4.91%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$1.43B
Gross profit
$967.37M
Operating income
$192.24M
Net income
$107.15M
Gross margin
67.5%
Net margin
7.5%
The net income has soared by 148% YoY and by 144% from the previous quarter
LIVN's net margin has soared by 143% year-on-year and by 143% since the previous quarter
The company's operating income rose by 19% YoY but it fell by 3.6% QoQ
LivaNova's revenue has increased by 12% YoY and by 3.3% from the previous quarter

Price vs fundamentals

How does LIVN's price correlate with its fundamentals

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
LIVN P/E details
P/E
39.89
P/B
3.53
P/S
2.98
EV/EBIT
24.98
EV/EBITDA
18.23
EV/Sales
2.85
LivaNova's EPS has surged by 148% YoY and by 144% QoQ
The price to book (P/B) is 41% higher than the 5-year quarterly average of 2.5 and 36% higher than the last 4 quarters average of 2.6
The equity rose by 17% year-on-year
The price to sales (P/S) is 35% higher than the last 4 quarters average of 2.2 and 10% higher than the 5-year quarterly average of 2.7
LivaNova's revenue has increased by 12% YoY and by 3.3% from the previous quarter

Efficiency

How efficient is LivaNova business performance
LivaNova's return on sales has surged by 192% QoQ
The return on equity has surged by 150% year-on-year and by 142% since the previous quarter
The company's return on assets has surged by 147% YoY and by 144% QoQ

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 93% higher than its total liabilities
LivaNova's quick ratio has decreased by 20% YoY and by 3.8% QoQ
The current ratio has declined by 16% year-on-year and by 2.2% since the previous quarter
LIVN's debt is 72% smaller than its equity
LIVN's debt to equity has dropped by 57% year-on-year and by 20% since the previous quarter
LIVN's debt has dropped by 50% year-on-year and by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.